Navigation Links
Gulfport-Biloxi Airport Welcomes Installation of New YoNaturals Healthy Vending Machines
Date:5/2/2008

Committed to improving the health of individuals through better snacking habits, YoNaturals, with its strong business foundation, and positive consumer trends, is positioned to make a meaningful impact. With support through their websites, http://www.yonaturals.com, and http://www.kidshealthyvending.com, YoNaturals hopes to educate children, parents, and decision-makers on the value of healthy snacking. They emphasize the importance in taking action now, and provide steps to begin making a positive, and healthy, change.


'/>"/>
SOURCE YoNaturals Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine news :

1. Akron-Canton Airport offering flu shot clinic for 90 days
2. New T-ray Source Could Improve Airport Security, Cancer Detection
3. Philly International Airport Tops AXEs Best and Worst Airports to Make a Connection
4. IDC Awarded Digital Radiography Contract With Beijing Capital Airport
5. Womens World Banking Welcomes New Network Member From Tunisia
6. MJGC Welcomes New Administrator-in-Training Shlomo Katz
7. MJGC Welcomes New Director of Social Work Alla Lerner
8. Patient Advocate Foundation Welcomes Leading Health Care Experts to Executive Board of Directors
9. Friends of WFP Welcomes World Hunger Relief Week
10. New York City Aesthetic Plastic Surgeon Welcomes top Skin Care Line into his Office
11. St. Pauls Senior Homes & Services Welcomes Some of San Diegos Neediest Displaced Seniors
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 3FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 4China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 2China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 3China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 4China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 5China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 6China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 7China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 8Watson Pharmaceuticals Receives FDA Approval for Generic PLAN B 28R 29 for Over the Counter Use 55640 1Watson Pharmaceuticals Receives FDA Approval for Generic PLAN B 28R 29 for Over the Counter Use 55640 2Meat Dairy Wont Up Odds for Breast Cancer 55638 1Meat Dairy Wont Up Odds for Breast Cancer 55638 2Meat Dairy Wont Up Odds for Breast Cancer 55638 3Pennsylvania Health Department Distributing Potassium Iodide to People Living Working Near Nuclear Power Plants 55636 1Pennsylvania Health Department Distributing Potassium Iodide to People Living Working Near Nuclear Power Plants 55636 2Pennsylvania Health Department Distributing Potassium Iodide to People Living Working Near Nuclear Power Plants 55636 3